A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
23hon MSN
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...
In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...
2d
Axios Vitals on MSNOregon researchers develop new test for pancreatic cancerResearchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic ...
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...
The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results